Drug intelligence / Profile preview

methylcobalamin + niacinamide + pyridoxine (Tanishq Life Care)

Development stage
Unknown
Lead developer
Tanishq Lifecare
Modality
Small Molecules
Administration
Intramuscular, Intravenous
01

Overview

Oxifit-M is a combination injectable formulation containing methylcobalamin (vitamin B12), niacinamide (vitamin B3), and pyridoxine (vitamin B6). Developed and marketed by Tanishq Lifecare, this therapeutic combination is designed to address various neurological and metabolic conditions. Methylcobalamin is a highly bioavailable form of vitamin B12 that plays a key role in maintaining nerve function and healing damaged nerves. Niacinamide supports healthy metabolism and cellular energy production. Pyridoxine is essential for the formation of red blood cells and proper nerve function. Together, these vitamins work synergistically to treat nutritional deficiencies, peripheral neuropathy (including diabetic neuropathy), megaloblastic anemia, and general fatigue.

Brand names
Oxifit-M
Other names
methylcobalamin + niacinamide + pyridoxinemethylcobalamin + niacinamide + pyridoxine hydrochloridemethylcobalamin, niacinamide and pyridoxinemethylcobalamin, niacinamide and pyridoxine hydrochloridemethylcobalamin/niacinamide/pyridoxine
02

Targets

MTR (Methionine synthase)NAMPTPDXK (Pyridoxal kinase)

Beyond the preview

Go deeper on methylcobalamin + niacinamide + pyridoxine (Tanishq Life Care).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on methylcobalamin + niacinamide + pyridoxine (Tanishq Life Care).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call